Autek China Inc. (SHE:300595)
16.55
-0.67 (-3.89%)
Feb 28, 2025, 2:45 PM CST
Autek China Revenue
Autek China had revenue of 547.74M CNY in the quarter ending September 30, 2024, with 1.55% growth. This brings the company's revenue in the last twelve months to 1.85B, up 13.15% year-over-year. In the year 2023, Autek China had annual revenue of 1.74B with 13.89% growth.
Revenue (ttm)
1.85B
Revenue Growth
+13.15%
P/S Ratio
8.00
Revenue / Employee
572.50K
Employees
3,229
Market Cap
14.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.74B | 211.85M | 13.89% |
Jan 1, 2023 | 1.53B | 230.27M | 17.78% |
Jan 1, 2022 | 1.30B | 424.38M | 48.74% |
Dec 31, 2020 | 870.66M | 223.76M | 34.59% |
Dec 31, 2019 | 646.90M | 188.48M | 41.12% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.93B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Sichuan Biokin Pharmaceutical | 5.85B |